LEP and metabolic syndrome: Components of MetS are linked to an increased risk of prostate cancer and MetS-related biomarkers such as insulin, insulin-like growth factor-1 (IGF-1), leptin and adiponectin are implicated in the involvement of tumorigenesis.7, 8